Study of FK463 for the Treatment of Invasive Aspergillosis

Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis

NCT02646774 ·Status: TERMINATED ·Phase: PHASE4

Single Ascending Oral Dose Study of F901318

NCT02394483 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric Participants

NCT03816176 ·Status: COMPLETED ·Phase: PHASE2

Olorofim Aspergillus Infection Study

NCT05101187 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis

NCT00412893 ·Status: COMPLETED ·Phase: PHASE3

Diagnostic and Management Strategies for Invasive Aspergillosis

NCT00816088 ·Status: COMPLETED

A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).

NCT00037206 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

F901318 Single Ascending Dose Study in Healthy Male Volunteers

NCT02142153 ·Status: COMPLETED ·Phase: PHASE1

Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU

NCT00048750 ·Status: TERMINATED ·Phase: PHASE3

Study of Micafungin in Patients With Invasive Candidiasis or Candidemia

NCT00105144 ·Status: COMPLETED ·Phase: PHASE3

Multiple Ascending Oral Dose Study of F901318 in Healthy Subjects

NCT02737371 ·Status: COMPLETED ·Phase: PHASE1

Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds

NCT04240886 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects

NCT01122368 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis

NCT00003031 ·Status: COMPLETED ·Phase: PHASE3

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

NCT00634049 ·Status: COMPLETED ·Phase: PHASE3

Efflux Pump Mediated Azole Resistance in Candida Albicans

NCT03659162 ·Status: UNKNOWN

Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)

NCT02180165 ·Status: COMPLETED ·Phase: PHASE3

Anidulafungin in Patients With Hematologic Malignancies

NCT01053884 ·Status: TERMINATED ·Phase: PHASE2

Study to Assess the Safety and Efficacy of Intravenous BSG005 in Patients With Invasive Fungal Infection

NCT06678113 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Multicentre Randomised Controlled Trial Comparing Two Strategies for the Diagnosis of Invasive Aspergillosis in High-risk Haematology Patients

NCT00163722 ·Status: COMPLETED ·Phase: PHASE3

PCR Based Detection of Azole Resistance in A. Fumigatus to Improve Patient Outcome.

NCT03121235 ·Status: COMPLETED

Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp

NCT02646800 ·Status: TERMINATED ·Phase: PHASE4

Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)

NCT00620074 ·Status: TERMINATED ·Phase: PHASE4

ATCF (Azole Therapy in Cystic Fibrosis)

NCT01576315 ·Status: COMPLETED ·Phase: PHASE2

Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis

NCT00531479 ·Status: COMPLETED ·Phase: PHASE3